Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
21.63 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 240.735 | 243.231 | 138.287 | 87.992 | 168.796 | 16.142 | 31.408 | 0.158 | 0.382 | 0.175 | 0.29 | 0.147 | 0.296 | 0.62 | 3.773 | 1.303 | 1.208 | 0.595 | 0.591 | 0.196 | 0 | 0.002 | 0.009 | 0.025 | 0.037 | 0.06 | 0.077 |
| Cost of Revenue
| 0 | 10.421 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.724 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0.002 | 0.003 | 0.034 | 0.037 |
| Gross Profit
| 240.735 | 232.81 | 138.287 | 87.992 | 168.796 | 16.142 | 31.408 | 0.158 | 0.382 | 0.175 | 0.29 | 0.147 | 0.296 | 0.62 | 3.773 | 1.303 | 0.484 | 0.595 | 0.591 | 0.196 | 0 | 0.002 | 0.003 | 0.023 | 0.034 | 0.027 | 0.04 |
| Gross Profit Ratio
| 1 | 0.957 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.401 | 1 | 1 | 1 | 0 | 0.962 | 0.324 | 0.916 | 0.923 | 0.44 | 0.517 |
| Reseach & Development Expenses
| 353.188 | 297.307 | 206.342 | 128.875 | 81.049 | 52.969 | 31.69 | 41.454 | 57.41 | 23.138 | 8.706 | 5.391 | 3.278 | 1.111 | 8.975 | 12.145 | 20.931 | 8.582 | 3.793 | 0.793 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 92.549 | 124.431 | 80.981 | 52.276 | 26.556 | 19.11 | 32.023 | 40.998 | 34.718 | 24.42 | 11.693 | 14.096 | 5.23 | 7.995 | 14.14 | 6,848.332 | 4,389.232 | 5,034.172 | 2.677 | 0.915 | 0 | 0 | 0 | 0 | 0.056 | 0.012 | 0.011 |
| Selling & Marketing Expenses
| -1.617 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,824.581 | -4,372.145 | -5,021.917 | 3.316 | 1.257 | 0 | 0 | 0 | 0 | 0.034 | 0.038 | 0.078 |
| SG&A
| 90.932 | 124.431 | 80.981 | 52.276 | 26.556 | 19.11 | 32.023 | 40.998 | 34.718 | 24.42 | 11.693 | 14.096 | 5.23 | 7.995 | 14.14 | 23.751 | 17.087 | 12.255 | 5.993 | 2.172 | 0.091 | 0.144 | 0.109 | 0.132 | 0.09 | 0.051 | 0.09 |
| Other Expenses
| 1.617 | 5.798 | 2.07 | -0.583 | 0 | 0.007 | 1.313 | 0.057 | 0.418 | 0.082 | -0.998 | 9,405.3 | 3,027.095 | 5,127.596 | 9,872.957 | 17,312.921 | 7,652.609 | 8,219.889 | 3.316 | 1.257 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 445.737 | 421.738 | 287.323 | 181.151 | 107.605 | 72.079 | 68.404 | 79.85 | 96.356 | 51.279 | 23.571 | 21.236 | 10.126 | 9.422 | 23.502 | 36.306 | 38.433 | 21.836 | 9.953 | 2.965 | 0.094 | 1.418 | 0.109 | 0.132 | 0.09 | 0.069 | 0.198 |
| Operating Income
| -205.002 | -178.507 | -149.036 | -93.159 | 61.191 | -55.936 | -36.996 | -81.743 | -95.974 | -53.276 | -24.589 | -21.089 | -9.83 | -8.802 | -19.729 | -35.003 | -37.949 | -21.241 | -9.363 | -2.769 | -0.094 | -1.416 | -0.106 | -0.109 | -0.056 | -0.042 | -0.159 |
| Operating Income Ratio
| -0.852 | -0.734 | -1.078 | -1.059 | 0.363 | -3.465 | -1.178 | -516.271 | -251.241 | -304.436 | -84.713 | -143.586 | -33.195 | -14.195 | -5.229 | -26.859 | -31.414 | -35.671 | -15.851 | -14.105 | 0 | -624.984 | -11.412 | -4.391 | -1.519 | -0.701 | -2.071 |
| Total Other Income Expenses Net
| -1.489 | 5.798 | 8.19 | 8.608 | 6.958 | 1.488 | 2.618 | 0.022 | 4.035 | -5.444 | -7.114 | -1.021 | 1.045 | 1.418 | -1.872 | -2.654 | -8.333 | 0.17 | 2.756 | 0.273 | 0 | 1.17 | -0.08 | -0.028 | -0.312 | -0.141 | -0.696 |
| Income Before Tax
| -206.491 | -172.709 | -140.846 | -84.551 | 68.148 | -54.448 | -34.378 | -81.721 | -91.938 | -58.72 | -31.703 | -22.111 | -8.785 | -7.336 | -19.158 | -35.117 | -37.949 | -21.924 | -6.988 | -2.496 | -0.094 | -0.246 | -0.186 | -0.138 | -0.368 | -0.011 | -0.855 |
| Income Before Tax Ratio
| -0.858 | -0.71 | -1.019 | -0.961 | 0.404 | -3.373 | -1.095 | -516.131 | -240.677 | -335.543 | -109.221 | -150.541 | -29.665 | -11.831 | -5.077 | -26.947 | -31.414 | -36.819 | -11.83 | -12.716 | 0 | -108.653 | -19.955 | -5.529 | -9.959 | -0.174 | -11.157 |
| Income Tax Expense
| 2.784 | 3.785 | 0.002 | 0.002 | 0.174 | 0.002 | 0.002 | 0.002 | 0.002 | 0.005 | 6.223 | -0.203 | -6.865 | -3.248 | 0.054 | -8.028 | -8.018 | -2.243 | -2.738 | 0.001 | 0.001 | -1.17 | 0.08 | 0.028 | -0.649 | 0.009 | 0.696 |
| Net Income
| -205.275 | -176.494 | -140.848 | -84.553 | 67.975 | -54.45 | -34.38 | -81.723 | -91.941 | -58.63 | -31.143 | -21.126 | -3.129 | -5.774 | -19.308 | -27.089 | -29.931 | -18.997 | -6.625 | -2.497 | -0.095 | -0.246 | -0.186 | -0.138 | 0.593 | -0.052 | -0.855 |
| Net Income Ratio
| -0.853 | -0.726 | -1.019 | -0.961 | 0.403 | -3.373 | -1.095 | -516.146 | -240.683 | -335.03 | -107.292 | -143.836 | -10.566 | -9.312 | -5.117 | -20.787 | -24.777 | -31.904 | -11.216 | -12.72 | 0 | -108.653 | -19.955 | -5.529 | 16.028 | -0.855 | -11.157 |
| EPS
| -1.91 | -1.67 | -1.36 | -0.84 | 0.72 | -0.65 | -0.47 | -1.34 | -1.6 | -1.25 | -1.3 | -1.9 | -0.44 | -0.9 | -4.27 | -6.91 | -8.35 | -5.95 | -2.61 | -1.88 | -0.25 | -32.47 | -25.97 | -19.48 | 97.4 | -10.16 | -175.33 |
| EPS Diluted
| -1.92 | -1.67 | -1.36 | -0.84 | 0.69 | -0.65 | -0.47 | -1.34 | -1.6 | -1.25 | -1.3 | -1.9 | -0.44 | -0.9 | -4.27 | -6.91 | -8.35 | -5.95 | -2.61 | -1.88 | -0.25 | -32.47 | -25.97 | -19.48 | 97.4 | -10.16 | -175.33 |
| EBITDA
| -175.672 | -162.288 | -132.58 | -87.217 | 65.63 | -51.237 | -29.687 | -78.461 | -89.602 | -47.383 | -20.108 | -19.34 | -8.517 | -9.833 | -18.163 | -33.248 | -35.68 | -19.427 | -8.949 | -2.673 | -0.094 | -1.407 | -0.103 | -0.102 | -0.048 | -0.015 | -0.055 |
| EBITDA Ratio
| -0.73 | -0.734 | -1.018 | -0.991 | 0.389 | -3.201 | -1.057 | -467.875 | -252.686 | -237.105 | -51.143 | -126.114 | -36.078 | -15.857 | -4.991 | -25.989 | -30.584 | -33.034 | -18.781 | -13.663 | 0 | -644.19 | -17.505 | -7.857 | 4.283 | -0.923 | 8.37 |